The coronavirus disease 2019 (COVID-19) pandemic continues to burden healthcare
systems worldwide. COVID-19 symptoms are highly heterogeneous, and the patient may be …

Since COVID-19 has affected global public health, there has been an urgency to find a
solution to limit both the number of infections, and the aggressiveness of the disease once …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) affects millions of people
worldwide. The article aims to review the therapeutic perspective on natural antioxidants …

COVID-19 is a zoonotic disease with devastating economic and public health impacts
globally. Being a novel disease, current research is focused on a clearer understanding of …

With an increased transmissibility but milder form of disease of the omicron variant of COVID-
19 and the newer antivirals often still out of reach of many populations, a refocus of the …

The emergence of the novel coronavirus in December 2019 in China marked the beginning
of a pandemic that impacted healthcare systems and economic life all over the world. The …

Hyperinflammation is related to the development of COVID‐19. Resveratrol is considered an
anti‐inflammatory and antiviral agent. Herein, we used a network pharmacological approach …

In the past 2 years, the coronavirus disease 2019 (COVID-19) pandemic has driven
investigational studies and controlled clinical trials on antiviral treatments and vaccines that …

Resveratrol is a phytoalexin produced by many plants as a defense mechanism against
stress-inducing conditions. The richest dietary sources of resveratrol are berries and grapes …

The COVID‐19 pandemic caused relatively high mortality in patients, especially in those
with concomitant diseases (ie, diabetes, hypertension, and chronic obstructive pulmonary …